Diabetes is a chronic condition affecting millions worldwide, with type 2 diabetes being the most common form. It occurs when the body becomes resistant to insulin or doesn't produce enough, leading to elevated blood sugar levels. Globally, diabetes rates are rising at an alarming pace, driven by poor diets, sedentary lifestyles, and limited access to preventive care.
In recent years, type 2 diabetes has emerged as a significant concern in children, a trend once rare but now linked to increasing rates of childhood obesity. The condition carries lifelong implications, including higher risks for heart disease, kidney damage, and reduced quality of life. Addressing this requires immediate action—raising awareness, promoting healthy habits, and ensuring equitable access to education and resources for all communities.
Aims
The Diabetes Interest Group brings together researchers with diverse expertise to tackle the challenges of diabetes through a holistic approach. The group's primary goals include:
- Exploring the molecular pathology of diabetes & developing innovative therapeutic drugs
- Creating accessible glucose monitoring devices
- Managing diabetes using natural herbal remedies
- Promoting physical and mental well-being
- Gestational diabetes and outcomes
- Addressing health inequalities and socioeconomic factors that significantly impact diabetes outcomes with a focus on behaviour change interventions addressing children
In our recent and ongoing work we have collaborated with partners at Tower Hamlets Council, Royal Holloway University, the University of Hertfordshire and, in our local community, Whitehall Park School and Whittington Hospital.
We welcome additional contributions and expertise, and we encourage you to join the group. Your involvement will bring us closer to achieving our goal of addressing diabetes effectively.
Theme Leader
Members
Dr Folasade Ajayi
Prof. Samantha Banbury
Dr Dee Bhakta
Chris Chamberlin
Prof. Chris Chandler
Dr Mabel Encinas
Prof. Yolanda Eraso
Dr Una Fairbrother
Dr Sandra Fernando
Dr Priyanka Ganguly
Prof. Lawrence Harbige
Dr Ben Hunter
Dr Joanne Hutchinson
Dr Samireh Jorfi
Preetpal Kainth
Prof. John Lodge
Dr Shawn McLaren
Prof. Lijun Shang
Dr Cassandra Terry
Prof. Ken White
Postgraduate Research Students
More information
- Designing novel therapeutic analogues of Human Islet Amyloid PolyPeptide for treating those with type 2 diabetes
- Understanding the role of hIAPP in molecular pathology in Type 2 Diabetes Mellitus
- Investigating the role of natural products for type 2 diabetes management in Iraq
- Improving Type 1 Diabetes Management by Changing Lifestyle Activities in Iraq
- Collaborative Approach to Address Type 2 Diabetes in Vulnerable Populations: Children of Ethnic Minority Backgrounds and Children with Disabilities
- Exploring the therapeutic potential of fenugreek in type 2 diabetes
- Working with diet and obesity and other complex disease, predisposing to diabetes in later life
- Scientific Outreach Grant - The Biochemistry Society.
- Cassandra Terry, Eirini Meimaridou, Samireh Jorfi, Medah Ramchurn, Mabel Encinas; “Sweet” detectives: children crack the case for a healthy future. Biochem (Lond) 2024; bio_2024_893.
- Haxhiraj M, White K, Terry C. The Role of Fenugreek in the Management of Type 2 Diabetes. International Journal of Molecular Sciences. 2024; 25(13): 6987.
- Terry C, White K, Hassan S, Sevcuka A (2023). Proteins behaving badly. Research outreach.
- Hassan S, White K, Terry C (2022). Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective. Bioscience Reports. 42(5), BSR20211297.
- Sevcuka A, White K, Terry C (2022). Molecular mechanisms linking IAPP and diabetes. Life. 12(4), 583.